Living With a PARP Inhibitor: Day-to-Day Guide

PARP inhibitors are targeted cancer drugs taken as pills at home. That makes daily life with them different from treatment given by infusion in a clinic. They are used most often for ovarian, breast, prostate, or pancreatic cancers that carry certain gene changes, such as a BRCA mutation. People usually stay on them as long as they keep working and side effects stay manageable.

Fatigue is one of the most reported side effects. It can be strong enough to affect daily activity and energy. Nausea is also common, and sometimes comes with vomiting, diarrhea, or a smaller appetite. Anemia is a drop in red blood cells. It is common enough that teams check for it as a matter of routine. It can cause tiredness, paleness, or shortness of breath. It sometimes needs its own fix, such as a dose change or, less often, a transfusion.

None of these side effects mean something has gone wrong. For many people they are expected parts of taking this medicine. Your care team has tools to manage them: dose changes, supportive medicines, and monitoring.

PARP inhibitors can lower blood cell counts. So regular blood tests, often monthly, are a standard part of taking this medicine. They are not an extra step saved for problems. These tests check red blood cells, white blood cells, and platelets. They also watch for a rare but serious bone marrow condition. It is called myelodysplastic syndrome or acute myeloid leukemia (MDS/AML). This has happened in a small share of people taking PARP inhibitors in clinical studies. It is seen more with longer-term use. That is why checks continue through treatment rather than stopping after the first few months. Tell your care team about unusual, long-lasting fatigue, easy bruising or bleeding, or repeated infections. These can be early signs worth checking.

A few practical habits help many people on PARP inhibitors:

• Pace activity across the day. Plan hard tasks for hours when your energy tends to be higher, rather than pushing through fatigue.
• Eat smaller, more frequent meals if nausea or appetite loss is an issue. Ask about anti-nausea medicine if diet changes alone do not help.
• Keep a simple symptom log, especially in the first weeks. You and your team can then spot patterns and adjust the plan.
• Report side effects early rather than waiting for a scheduled visit. Dose changes are a normal part of managing this treatment, not a sign that it has failed.

• Call 911 or go to an emergency department if you get sudden shortness of breath, chest pain that sharpens when you breathe in, or one leg swells and turns painful. The olaparib label warns about clots in the legs and lungs.
• Contact your cancer team straight away, day or night, if your temperature reaches 100.4°F (38°C) or higher, or you get shaking chills, while taking this medicine. It lowers white cells as well as red, and CDC treats fever during cancer drug treatment as a medical emergency rather than something to phone about in the morning. If they cannot be reached quickly, go to an emergency department and tell staff you are on a PARP inhibitor.
• Call your care team the same day if a new cough or new breathlessness starts without a fever. The label lists these as possible signs of lung inflammation, and the pill is paused while the cause is checked.
• Call your care team within a day or two if bruises turn up without a knock, your gums bleed when you brush, or the tiredness deepens week by week between blood tests. These point at the counts this medicine is monitored for.

• National Cancer Institute — Definition of PARP Inhibitor
• CDC — Fever During Chemotherapy
• FDA — LYNPARZA (olaparib) Prescribing Information